Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Hepatocellular carcinoma
Shunsuke Kondo
, Hideki Ueno
, Chigusa Morizane
, Takuji Okusaka
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatocellular Carcinoma
100%
Advanced Hepatocellular Carcinoma
60%
Sorafenib
60%
Randomized Controlled Trial
40%
Cytotoxic Therapy
40%
Clinical Trials
20%
Placebo
20%
Overall Survival
20%
Chemotherapy
20%
Japan
20%
Tumor Growth
20%
Molecular Targets
20%
Systemic Chemotherapy
20%
Tumor Angiogenesis
20%
Survival Benefit
20%
Progression-free Survival
20%
Disease Control Rate
20%
New Agents
20%
Systemic Agents
20%
Randomized Protocol
20%
Asian-Pacific Region
20%
Oral Fluoropyrimidine
20%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Sorafenib
37%
Randomized Controlled Trial
25%
Cytotoxic Chemotherapy
25%
Clinical Trial
12%
Tumor Progression
12%
Placebo
12%
Progression Free Survival
12%
Overall Survival
12%
Tumor Angiogenesis
12%
Treatment Development
12%
Fluoropyrimidine
12%
Diseases
12%
Oral
12%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Sorafenib
37%
Randomized Controlled Trial
25%
Chemotherapy
25%
Cytotoxic Chemotherapy
25%
Clinical Trial
12%
Overall Survival
12%
Tumor Growth
12%
Placebo
12%
Progression Free Survival
12%
Fluoropyrimidine
12%
Diseases
12%